Page last updated: 2024-08-05 12:31:47

organic hydroxy compound

An organic compound having at least one hydroxy group attached to a carbon atom.

ChEBI ID: 33822

Members (11)

MemberDefinitionRole
4-hydroxymidazolamAn imidazobenzodiazepine that is midazolam which is substituted by a hydroxy group at position 4. It is the minor hydroxylated metabolite of the anesthetic, midazolam.4-hydroxymidazolam
5-hydroxyuridineA member of the class of uridines that is uridine in which the hydrogen at position 5 of the uracil ring is substituted by a hydroxy group.5-hydroxyuridine
cassaineA tricyclic diterpenoid isolated from several plant species of the genus Erythrophleum.cassaine
e 3040A member of the class of benzothiazoles that is 1,3-benzothiazole substituted by a methylnitrilo group, (pyridin-3-yl)methyl group, methyl group, hydroxy group and methyl group at position 2,4,5,6 and 7, respectively. It is a dual inhibitor of 5-lipoxygenase and thromboxane A2 synthetase and exhibits anti-inflammatory properties. The drug was being developed by Eisai (Tokyo, Japan) for the treatment of bowel disease.E3040
gu 7Licopyranocoumarin
INDYA member of the class of benzothiazoles that is 2,3-dihydro-1,3-benzothiazole substituted by 2-oxopropylidene, ethyl, and hydroxy groups at positions 2, 3 and 5, respectively. It is an ATP-competitive inhibitor of Dyrk1A and Dyrk1B (IC50 of 0.24 muM and 0.23 muM, respectively).INDY
karounidiolKarounidiol
oripavineA morphinane alkaloid with formula C18H19NO3. It is the major metabolite of thebaine.oripavine
robustic acid6-hydroxy-5-methoxy-7-(4-methoxyphenyl)-2,2-dimethyl-8-pyrano[3,2-g][1]benzopyranone
sesaminolA furofuran that is cis-tetrahydro-1H,3H-furo[3,4-c]furan substituted by a 6-hydroxy-1,3-benzodioxol-5-yl group at position 1S and a 1,3-benzodioxol-5-yl group at position 4S. It is metabolite found in sesame seeds.sesaminol
sethoxydimSethoxydim

Research

Studies (209)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-199028 (13.40)18.7374
1990's39 (18.66)18.2507
2000's54 (25.84)29.6817
2010's69 (33.01)24.3611
2020's19 (9.09)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials3 (1.42%)5.53%
Reviews7 (3.32%)6.00%
Case Studies2 (0.95%)4.05%
Observational0 (0.00%)0.25%
Other199 (94.31%)84.16%